I agree that this site is using cookies. You can find further informations here.
X
Veerle Vanvoorden
24  results:
Search for persons X
?
1

P-78/1122/Quality of Life Outcomes in Eortc Cancer Clinical..:

Henning Flechtner ; Andrew Bottomley ; Fabio Efficace...
Quality of Life Research.  14 (2005)  9 - p. 2052 ff. , 2005
Link: https://www.jstor.org/st..
 
?
2

# 1234/What Is the Added Clinical Value of Health Related Q..:

Andrew Bottomley ; Fabio Efficace ; Veerle Vanvoorden...
Quality of Life Research.  12 (2003)  7 - p. 766 ff. , 2003
Link: https://www.jstor.org/st..
 
?
3

# 1384/The Impact on Clinical Decision Making of Randomized..:

Fabio Efficace ; Andrew Bottomley ; Jane M. Blazeby.
Quality of Life Research.  12 (2003)  7 - p. 767 ff. , 2003
Link: https://www.jstor.org/st..
 
?
4

Database Review of Quality of Life Studies in Eortc Cancer ..:

Henning Flechtner ; Andrew Bottomley ; Veerle Vanvoorden
Quality of Life Research.  11 (2002)  7 - p. 676 ff. , 2002
Link: https://www.jstor.org/st..
 
?
5

43778 Bimekizumab maintenance of response and safety in pat..:

Strober, Bruce ; Puig, Luis ; Blauvelt, Andrew...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB21 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Safety and efficacy of bimekizumab through 2 years in patie..:

Thaçi, Diamant ; Vender, Ron ; de Rie, Menno A...
British Journal of Dermatology.  188 (2023)  1 - p. 22-31 , 2023
Link: https://doi.org/10.1093/..
 
?
7

Bimekizumab Efficacy and Safety in Japanese Patients with P..:

Asahina, Akihiko ; Okubo, Yukari ; Morita, Akimichi...
Dermatology and Therapy.  13 (2023)  3 - p. 751-768 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Bimekizumab maintenance of response through 3 years in pati..:

Strober, Bruce ; Tada, Yayoi ; Mrowietz, Ulrich...
British Journal of Dermatology.  188 (2023)  6 - p. 749-759 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Bimekizumab efficacy and safety in patients with moderate t..:

Strober, Bruce ; Paul, Carle ; Blauvelt, Andrew...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. 486-495 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Bimekizumab in patients with moderate to severe plaque psor..:

Pinter, Andreas ; Strober, Bruce ; Rosmarin, David...
SKIN The Journal of Cutaneous Medicine.  6 (2022)  6 - p. s73 , 2022
Link: https://doi.org/10.25251..
 
?
11

Bimekizumab maintenance of response through three years in ..:

Strober, Bruce ; Tada, Yayoi ; Mrowietz, Ulrich...
SKIN The Journal of Cutaneous Medicine.  6 (2022)  6 - p. s65 , 2022
Link: https://doi.org/10.25251..
 
?
12

34310 Bimekizumab early responses in patients with plaque p..:

Feldman, Steven R. ; Gottlieb, Alice B. ; Soung, Jennifer...
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB145 , 2022
Link: https://doi.org/10.1016/..
 
?
13

34321 Bimekizumab efficacy and safety through 96 weeks in p..:

Strober, Bruce ; Paul, Carle ; Blauvelt, Andrew...
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB146 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Bimekizumab efficacy and safety in patients with moderate-t..:

Kokolakis, Georgios ; Warren, Richard B ; Strober, Bruce...
British Journal of Dermatology.  188 (2022)  3 - p. 330-340 , 2022
Link: https://doi.org/10.1093/..
 
?
15

27464 Bimekizumab vs adalimumab in plaque psoriasis: Higher..:

Blauvelt, Andrew ; Thaçi, Diamant ; Papp, Kim A....
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB146 , 2021
Link: https://doi.org/10.1016/..
 
1-15